Of the patients in the study, 16.41% received originator products, 87.22% received biosimilars, 3.6% received both a biosimilar and an originator, and 6.2% were treated with both adalimumab and ...
Reuters Graphics Reuters Graphics Reuters Graphics ... In some cases, lower-cost generic or biosimilar versions of the original branded drugs are already available outside the U.S. Generic ...
SHANGHAI, China I September 2, 2024 I Shanghai Henlius Biotech, Inc. (2696.HK) announced the investigational new drug (IND) application for clinical trial of HLX17, a pembrolizumab biosimilar ...
The Graphic Design Exercises for 16 to 18 Year Olds Online Short Course explores visual language and aims to lay the groundwork for developing graphic design skills. The course focuses on three topics ...
The Hyderabad-based firm is adopting a two-pronged approach to biosimilars by developing innovative products as well as contract manufacturing. Through its CuraTeQ Biologics, a wholly-owned ...
With the end of the second quarter comes expense reports, new biosimilar business deals, and insights into how federal policy impacts biosimilar company pursuits. With the end of the second quarter ...
Reimbursement add-on The Medicare provision (PDF) in question consists of a temporary, five-year boost in Medicare Part B reimbursement rates for biosimilar products. The standard Part B ...
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has secured market entry for its proposed biosimilar to Stelara in Europe, the UK, Canada, and Japan. The company announced today ...
Some graphic forms are so ubiquitous today that it’s hard to remember that they were ever novel. But of course, there was a first time for everything. A new and comprehensive visual survey of ...
MedImpact Healthcare Systems is providing access to two Humira biosimilars: Alvotech/Teva's Simlandi (adalimumab-ryvk) and Sandoz’s unbranded adalimumab-adaz. Beginning in January 2025, patients new ...
Regeneron is going after Sandoz in a New Jersey federal court over Sandoz’s recently-approved drug Enzeevu, a biosimilar to Regeneron’s blockbuster eye tr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback